Cargando…
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
PURPOSE: NK012 is a polymeric micelle formulation of SN-38, the active metabolite of irinotecan. We evaluated the efficacy and safety of NK012 in Japanese patients with unresectable metastatic colorectal cancer. METHODS: We conducted a multicenter open-label phase II trial of NK012 monotherapy in 58...
Autores principales: | Hamaguchi, Tetsuya, Tsuji, Akihito, Yamaguchi, Kensei, Takeda, Koji, Uetake, Hiroyuki, Esaki, Taito, Amagai, Kenji, Sakai, Daisuke, Baba, Hideo, Kimura, Masami, Matsumura, Yasuhiro, Tsukamoto, Tetsuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267673/ https://www.ncbi.nlm.nih.gov/pubmed/30284603 http://dx.doi.org/10.1007/s00280-018-3693-6 |
Ejemplares similares
-
A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma
por: Ri, Masaki, et al.
Publicado: (2017) -
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
por: Matsumura, Y, et al.
Publicado: (2004) -
Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors
por: Mukai, Hirofumi, et al.
Publicado: (2016) -
Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy
por: Xie, Jing, et al.
Publicado: (2016) -
One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion
por: Sun, Xuanrong, et al.
Publicado: (2019)